GLYCINE, N-(2-METHYL-1-OXO-2-PROPENYL)GLYCYL-6-AMINOHEXANOYL-, (4S)-4-ETHYL-3,4,12,14-TETRAHYDRO-3,14-DIOXO-1H-PYRANO(3',4':6,7)INDOLIZINO(1,2-B)QUINOLIN-4-YL ESTER
UNII LB0R670UJD
Substance Identification & Data
This profile provides standardized clinical and technical data for Glycine, N-(2-methyl-1-oxo-2-propenyl)glycyl-6-aminohexanoyl-, (4s)-4-ethyl-3,4,12,14-tetrahydro-3,14-dioxo-1h-pyrano(3',4':6,7)indolizino(1,2-b)quinolin-4-yl Ester, uniquely identified by the FDA Unique Ingredient Identifier (UNII) LB0R670UJD.
Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 222974-56-3 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.
Detailed Substance Profile
C34H37N5O8 PADXFHBBNBUCNR-UMSFTDKQSA-N Synonyms and Nomenclature
This section provides a complete list of nomenclature and identifier mappings for Glycine, N-(2-methyl-1-oxo-2-propenyl)glycyl-6-aminohexanoyl-, (4s)-4-ethyl-3,4,12,14-tetrahydro-3,14-dioxo-1h-pyrano(3',4':6,7)indolizino(1,2-b)quinolin-4-yl Ester. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.